Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Fractyl Health, a clinical-stage metabolic therapeutics company targeting obesity and type 2 diabetes, announced CEO Dr. Harith Rajagopalan will present and engage in meetings at the H.C. Wainwright and Morgan Stanley healthcare investment conferences in September 2026. The events will be webcast and focus on the company’s advanced metabolic diseas…
Balchem Corporation, a global specialty ingredient manufacturer serving health and nutrition markets, announced its participation in the 9th Annual Wells Fargo Consumer Conference. Senior executives including the CEO, CFO, and Senior Director of Investor Relations will present, highlighting the company's multi-segment operations across human nutrit…
Radiopharm Theranostics announced positive Phase 1 trial results for RAD301, a novel Gallium-68 labeled peptide targeting αvβ6-integrin in pancreatic ductal adenocarcinoma (PDAC) patients. The trial demonstrated favorable safety, significant tumor uptake, and selective biodistribution, indicating RAD301’s potential to improve pancreatic cancer imag…
Fate Therapeutics announced the presentation of clinical and pre-clinical data for its off-the-shelf CAR T-cell therapies FT819 and FT839 at the Congress of Clinical Rheumatology West meeting. The Phase 1 trial data for FT819 demonstrates favorable safety, early and sustained efficacy in systemic lupus erythematosus (SLE) patients, supporting advan…
SailPoint, Inc., a leader in enterprise identity security, announced its financial results for the fiscal second quarter ended July 31, 2026, and hosted a conference call to discuss its performance and outlook. The company emphasizes its role in securing digital and human identities for modern enterprises through its identity-first security platfor…
Destination XL Group, Inc., a leading Big + Tall men's apparel retailer, reported Q2 FY2026 sales of $111.6 million, a 3.4% decline from the prior year, with comparable sales down 3.5%. Despite sales pressure and ongoing economic headwinds, net income improved to $2.0 million aided by a $4.6 million tariff refund. The company is focusing on strateg…
Lightbridge Corporation has secured access to the Advanced Test Reactor (ATR) loop testing facility at Idaho National Laboratory to irradiate its Lightbridge Fuel™ rodlets under commercial reactor conditions. This milestone enables critical data collection for fuel performance validation and supports progression toward fuel qualification and commer…
MapLight Therapeutics, a clinical-stage biopharmaceutical company specializing in treatments for central nervous system disorders, announced its management team's participation in the Morgan Stanley 24th Annual Global Healthcare Conference. The company aims to highlight its innovative discovery platform targeting neural circuits linked to diseases,…
Actuate Therapeutics reported promising preclinical data demonstrating that elraglusib, a GSK-3β inhibitor, when combined with RAS inhibitors zoldonrasib and daraxonrasib, exhibits synergistic antitumor activity in multiple murine and human pancreatic cancer models, including those resistant to FOLFIRINOX chemotherapy. These results, supported by i…
Tilray Brands' subsidiary, Breckenridge Distillery, introduces a limited-edition whiskey collection honoring 40 years of 'The Drive' and its partnership with the Denver Broncos. The collection includes award-winning bourbon blends and a nostalgic whiskey seltzer, available in Colorado to enhance Broncos game-day experiences. This launch underscores…
Opus Genetics announced positive interim data from the low-dose cohort of its ongoing Phase 1/2 trial for OPGx-BEST1, a gene therapy targeting BEST1-related inherited retinal diseases. All participants showed meaningful improvements in visual function, with favorable safety and structural retinal improvements also reported. The company achieved ali…
CoinShares PLC announced that CEO Jean-Marie Mognetti will attend the Oppenheimer Fintech Leaders Conference in New York on September 15, 2026. He will conduct one-on-one meetings with investors, discussing the company's business, recent progress, and industry outlook. The company specializes in digital asset management and is publicly listed on Na…
J.P. Morgan downgraded Coloplast from neutral to underweight and reduced its December 2027 price target to 377 Danish crowns, citing a disconnect between the stocks premium valuation and a deteriorating earnings profile. The bank applied a probability-weighted framework across three mid-term guidance scenarios and highlighted near-term risks inclu…
Raymond James says National Bank of Canada (TSE:NA) appears to be entering a short-term corrective phase after slipping beneath the 50-day moving average and showing signs of weakening momentum and relative strength. The broker outlines a series of support levels that, if broken on sustained closes, would open the door to larger downside tests and …
RBC Capital Markets warned that the S&P 500 could experience a 5-10% pullback in the near term, identifying seasonality, the U.S. midterm elections and the unresolved Iran war as primary catalysts. The firm stressed lingering investor concern about inflation, the Federal Reserve and interest rates, and noted small-cap underperformance since late Ju…
Evommune shares fell sharply in pre-market trading after the company disclosed that its EVO756 drug candidate did not meet primary or secondary endpoints in a Phase 2b study for moderate-to-severe atopic dermatitis. The setback follows an earlier Phase 2b miss in chronic spontaneous urticaria this year and raises questions about near-term drivers o…
Shares of Lithium Americas Corp rose about 3.3% in pre-market trade after JPMorgan upgraded the stock from Neutral to Overweight and set a $6.00 target (C$8.00), implying roughly 100% upside from the prior close. The bank's internal commodity refresh raised lithium price assumptions, boosting net asset value projections for the company starting in …
Figure Technology Solutions shares climbed in pre-market action after BofA Securities raised its rating from Underperform to Neutral and increased its price target to $49 from $31, citing a higher price-to-earnings multiple and a stronger revenue growth outlook through 2028. The bank's reassessment centers on the rapid expansion of Figure Connect, …
GE Aerospace is acquiring Consolidated Precision Products for $12 billion to secure production of precision cast metal components used in jet engine turbine blades. The move gives GE direct access to a critical supplier, addressing long-standing bottlenecks in castings and forgings that have dogged aerospace manufacturers since the pandemic. The de…
Braze Inc. shares plunged in premarket trading after the customer engagement software provider reported a Q2 that beat estimates on both EPS and revenue but issued a Q3 profit outlook below analyst expectations. Investors reacted to the guidance shortfall alongside signs of slowing growth and compressed cash flow margins, while broader market weakn…
Burberry shares fell about 3.3% to trade near 1,043p following an HSBC downgrade from Buy to Hold and a lower price target of 1,200p (from 1,350p). HSBC said the gains tied to the company's recent turnaround are largely reflected in the current share price, leaving limited scope for further upgrades to sales or earnings. The bank also raised its se…
Target Hospitality's stock tumbled about 7.1% in pre-market trading after controlling shareholders sold a large block of shares in a discounted secondary offering. The sale, upsized to 14 million shares at $18.50 each and raising roughly $259 million in gross proceeds for the sellers, set a de facto price ceiling below the prior close and weighed o…
Meta is trading at $634 with a $1.56T market cap, a mid-20s P/E and healthy free cash flow. Recent product integrations (Muse personal AI) and steady ad demand argue for a rebound; rising rates and insider selling are real headwinds. This trade targets $700 over a mid-term horizon while keeping a clear stop below structural technical support.
Casey’s General Stores shares tumbled about 8.7% in pre-market trading after the company reported fiscal first-quarter results that beat consensus on both adjusted EPS and revenue but revealed softer same-store performance, a small decline in fuel gallons sold and rising operating costs. Management maintained fiscal 2027 guidance without an upward …
ServiceTitan shares plunged in pre-open trading after an after-hours selloff following its fiscal Q2 2027 report. Revenue topped expectations, but slowing Gross Transaction Volume, cautious Q3 revenue guidance, a slight adjusted EPS miss and a change in sales leadership drove investor concern and analyst price-target adjustments.
